• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center found that people with a form of mild cognitive impairment (MCI), a risk factor for developing Alzheimer’s disease, have twice the risk of dying compared with cognitively normal people. Those with dementia have three times the risk. The findings are being presented at the Alzheimer’s Association International Conference in Vancouver this week.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS).

• share
• favorite_border

Patients vary widely in their response to concussion, but scientists haven’t understood why. Now, using a new technique for analyzing data from brain imaging studies, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that concussion victims have unique spatial patterns of brain abnormalities that change over time.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology of Yeshiva University have found that personality traits like being extroverted, enjoying laughter and staying engaged may also be part of the longevity genes mix that allows some people to reach age 100 and beyond. The findings published online May 21 in the journal Aging.

• share
• favorite_border

U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, M.D., will deliver the keynote address at the 2012 commencement ceremony for Albert Einstein College of Medicine of Yeshiva University. Einstein’s 54th graduation will take place at Lincoln Center’s Avery Fisher Hall Wednesday, May 30 at 6:30 p.m.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a molecule that inhibits the action of estrogen. This female hormone plays a key role in the growth, maintenance and repair of reproductive tissues and fuels the development of endometrial and breast cancers. The molecule, discovered in animal studies, could lead to new therapies for preventing and treating estrogen-related diseases in humans. The findings were published online April 26 in the PNAS Plus.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with Nurses’ Health Study investigators have shown that levels of certain related proteins found in blood are associated with a greatly reduced risk for developing type 2 diabetes up to a decade or more later. The findings, published today in the online edition of Diabetes, could open a new front in the war against diabetes.

• share
• favorite_border

Meredith Hawkins, M.D., professor of medicine and director of the Global Diabetes Initiative at Albert Einstein College of Medicine of Yeshiva University, will receive the American Federation for Medical Research’s (AFMR) highest honor for medical research, the Outstanding Investigator Award. The prestigious prize is given annually to one exceptional investigator aged 45 or younger for excellence in biomedical research.

• share
• favorite_border

Three leading cancer researchers at Albert Einstein College of Medicine of Yeshiva University have been selected to chair symposia at this year’s annual meeting of the American Association for Cancer Research, which will be held in Chicago from March 31 to April 4.

• share
• favorite_border

Members of Albert Einstein College of Medicine of Yeshiva University’s graduating class celebrated another strong year for residency placements in competitive specialties and prestigious programs at this year’s Match Day. Representing the culmination of their medical school education, Match Day marked the transition of Einstein’s class of 2012 into the post-graduate phase of their training – when they will practice medicine in a clinical setting under the supervision of fully licensed physicians.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University has earned an “A,” the top mark, for its conflict-of-interest policies from the American Medical Student Association (AMSA), the oldest and largest independent association of physicians-in-training in the United States.

• share
• favorite_border

A new study by researchers at Albert Einstein College of Medicine found that young children with sleep-disordered breathing are prone to developing behavioral difficulties such as hyperactivity and aggressiveness, as well as emotional symptoms and difficulty with peer relationships.

• share
• favorite_border

In a surprising finding with significant implications for older women, researchers at Albert Einstein College of Medicine of Yeshiva University and NYU School of Medicine have found that high levels of triglycerides (blood fats) are the strongest risk factor for the most common type of stroke in older women – more of a risk factor than elevated levels of total cholesterol or of low-density lipoprotein (LDL) cholesterol (known as “bad” cholesterol). The study appears online today in Stroke.

• share
• favorite_border

Communications and marketing strategist Paul Moniz has been named managing director of communications and marketing at Albert Einstein College of Medicine of Yeshiva University after a successful three-and-a-half-year run as a director in the College of Medicine’s Philip and Rita Rosen Department of Communications and Public Affairs. Mr. Moniz is a seasoned communications professional and an award-winning former broadcast journalist with 20 years of public relations and journalism experience.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient’s tumor will be life threatening. The biomarker is considered particularly promising because it can detect the level of risk immediately following diagnosis. This discovery could become a component of a new test to guide how aggressively those with head and neck tumors should be treated. The findings were published online January 9 in the American Journal of Pathology.

• share
• favorite_border

What is it like to be a practicing physician in today’s world of breakthrough technologies, expanding therapeutic options, insurance challenges, health policy debates and increasingly savvy e-patients? Faculty members at Albert Einstein College of Medicine of Yeshiva University will provide a rare window into the lives of doctors navigating this evolving landscape with “The Doctor’s Tablet,” a new blog launched today on Einstein’s website.

• share
• favorite_border

To address the prospects for personalized medicine in diabetes, investigators from Albert Einstein College of Medicine have surveyed the field for existing research and published their findings in the January issue of Health Affairs. The authors are Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean and former director of the National Institute of Diabetes and Digestive and Kidney Diseases at the NIH, and Meredith Hawkins, M.D., director of Einstein’s Global Diabetes Initiative.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered the first known mechanism by which cells control the survival of messenger RNA (mRNA)—arguably biology’s most important molecule. The findings pertain to mRNAs that help regulate cell division and could therefore have implications for reversing cancer’s out-of-control cell division. The research is described in today’s online edition of the journal Cell.

• share
• favorite_border

New York City Council Member James Vacca, along with administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University, celebrated the re-launch of Einstein’s Gruss Magnetic Resonance Research Center.

• share
• favorite_border

An antimalarial agent developed by researchers at Albert Einstein College of Medicine of Yeshiva University proved effective at clearing infections caused by the malaria parasite most lethal to humans – by literally starving the parasites to death. The study, published in the November 11, 2011 issue of PLoS ONE, was led by senior author Vern Schramm, Ph.D., professor and Ruth Merns Chair in Biochemistry at Einstein.

• share
• favorite_border

In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to establish a clinical site for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). One of only 25 such federally-funded centers in the country, the Einstein-Montefiore site was created in partnership with Einstein affiliates Beth Israel Medical Center in Manhattan and the North Shore-Long Island Jewish Health System. The NeuroNEXT network and its centers were established with grants from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.

• share
• favorite_border

Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University. The findings, observed in nearly 5,000 postmenopausal women, appear in the November 29 online edition of the British Journal of Cancer.

• share
• favorite_border

Using advanced imaging techniques and cognitive tests, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have shown that repeatedly heading a soccer ball increases the risk for brain injury.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that cancer cells tap into a natural recycling system to obtain the energy they need to keep dividing. In a study with potential implications for cancer treatments, Einstein researchers used genetic manipulation to turn off this recycling system within the walls of cells and stop both tumor growth and metastasis (cancer spread). The findings were published in today’s online edition of Science Translational Medicine.

• share
• favorite_border

New York State Senator Jeffrey D. Klein joined administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University last Friday to officially open their new Cognitive Neurophysiology Laboratory. Several pieces of high-tech diagnostic and monitoring equipment, including advanced electroencephalogram (EEG) systems, stimulus delivery equipment and specialized video recording devices, were purchased through a $1 million capital grant that Senator Klein secured for Einstein in the 2009-2010 budget cycle.

• share
• favorite_border

Researchers at the Albert Einstein College of Medicine of Yeshiva University have uncovered a mechanism that governs how cells become specialized during development. Their findings could have implications for human health and disease and appear in the November 10 online edition of the journal Cell.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans. The findings, published today in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes.

• share
• favorite_border

The National Cancer Institute (NCI) has awarded Albert Einstein College of Medicine of Yeshiva University two grants totaling $8 million to study the microenvironments that drive the spread of cancer from the primary tumor to other parts of the body in the process known as metastasis.

• share
• favorite_border

A panel of prominent medical school deans from across the country convened yesterday in New York City to discuss the future of annual medical school rankings issued by U.S. News & World Report, which are now celebrating their 20th anniversary.

• share
• favorite_border

Nir Barzilai, M.D., director of the Institute for Aging Research at Albert Einstein College of Medicine of Yeshiva University, will help lead a newly formed centenarian consortium for the Archon Genomics X PRIZE presented by Medco. The $10 million dollar incentivized prize competition, which was announced today, challenges teams of scientists and entrepreneurs to sequence the complete genomes of 100 healthy centenarians in 30 days. Intended to help usher in an era of personalized medicine and learn from the genetic advantages of the exceptionally long-lived, the competition tasks teams with delivering medical quality genome sequencing results for $1,000 per centenarian.

• share
• favorite_border

Shinya Yamanaka, M.D., Ph.D., the internationally renowned scientist known for his pioneering work generating the first induced pluripotent stem cells (iPS cells), delivered the 2011 Lasker Lecture at Albert Einstein College of Medicine of Yeshiva University today. A standing-room-only crowd was on-hand for his presentation covering his initial groundbreaking research with iPS cells and his ongoing research in the field.

• share
• favorite_border

The Eunice Kennedy Shriver National Institute for Child Health and Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University $5.7 million to fund the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC). The grant supports Einstein’s ongoing efforts to improve the lives of children with intellectual and developmental disabilities (IDD) through combined basic science research and clinical practice.

• share
• favorite_border

The Eunice Kennedy Shriver National Institute of Child Health & Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University and collaborators at the Children’s Hospital of Philadelphia a five-year, $6.7 million grant to study the genetics of both rare and common congenital heart abnormalities known as conotruncal defects.

• share
• favorite_border

The Institute of Medicine (IOM) released a report last Friday that provides guidance to U.S. public health officials to develop plans to pre-position antibiotics that can be distributed to the general public in the case of a large-scale anthrax attack. Tia Powell, M.D., director of the Montefiore Einstein Center for Bioethics and the Einstein Cardozo Masters of Science in Bioethics program, was vice-chair of the 16-member Committee Prepositioned Medical Countermeasures for the Public, which issued the report.

• share
• favorite_border

People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine of Yeshiva University. Their findings, in the September 28 online edition of The Journal of Clinical Endocrinology and Metabolism, suggest that physicians should more diligently monitor vitamin D levels in patients being treated with oral steroids.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria. The findings, which could improve vaccines against pneumonia, appear in the September/October issue of mBio, the online journal of the American Society for Microbiology.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice. Their study appeared in the September 1 online edition of the Journal of Rheumatology.

• share
• favorite_border

As the United Nations prepares for its first-ever, high-level summit to address the growing burden of non-communicable diseases, the Global Health Center at Albert Einstein College of Medicine of Yeshiva University, in collaboration with the International Diabetes Federation (IDF), will host the Global Diabetes Symposium in midtown Manhattan. On Sunday, September 18, from 2 to 8 p.m., leaders in global diabetes, diabetes prevention and treatment.

• share
• favorite_border

In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine that they have developed a tuberculosis (TB) vaccine candidate that proved both potent and safe in animal studies. According to the World Health Organization, TB kills an estimated 1.7 million people each year and infects one out of three people around the globe. With drug-resistant strains spreading, a vaccine for preventing TB is urgently needed.

• share
• favorite_border

In the largest cancer study of firefighters ever conducted, research published in this week’s 9/11 Special Issue of The Lancet found that New York City firefighters exposed to the 9/11 World Trade Center (WTC) disaster site were at least 19 percent more likely to develop cancer in the seven years following the disaster as their non-exposed colleagues and up to 10 percent more likely to develop cancer than a similar sample from the general population.

• share
• favorite_border

A leading medical geneticist, Harry Ostrer, M.D., will join the faculty of Albert Einstein College of Medicine of Yeshiva University and Montefiore, the University Hospital and academic medical center for Einstein, to lead the development and clinical implementation of genetic testing at the two institutions. Dr. Ostrer will be named professor of pathology and of genetics at Einstein and director of genetic and genomic testing at Montefiore. His appointments begin September 2.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have helped identify a cellular protein that is critical for infection by the deadly Ebola virus. The findings, published in today’s online edition of Nature, suggest a possible strategy for blocking infection due to Ebola virus, one of the world’s most lethal viruses and a potential bioterrorism agent.

• share
• favorite_border

While many in the city leave town for the last two weeks of August, students from across the country and around the world will descend on the Bronx to launch their medical careers at Albert Einstein College of Medicine of Yeshiva University. One hundred and eighty-three first-year medical students will arrive on Einstein’s Jack and Pearl Resnick campus Monday, August 15 for a week of orientation and welcoming events that will introduce them to the campus, faculty members and each other.

• share
• favorite_border

People who live to 95 or older are no more virtuous than the rest of us in terms of their diet, exercise routine or smoking and drinking habits, according to researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings, published today in the online edition of Journal of the American Geriatrics Society, suggests that “nature” (in the form of protective longevity genes) may be more important than “nurture” (lifestyle behaviors) when it comes to living an exceptionally long life.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have developed the first fluorescent protein that enables scientists to clearly "see" the internal organs of living animals without the need for a scalpel or imaging techniques that can have side effects or increase radiation exposure.

• share
• favorite_border

A longstanding medical mystery – why so many people with HIV experience memory loss and other cognitive problems despite potent antiretroviral therapy – may have been solved by researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings are published in the June 29 issue of The Journal of Neuroscience.

• share
• favorite_border

Gordon F. Tomaselli, M.D., who earned his medical degree from Albert Einstein College of Medicine of Yeshiva University in 1982, will become president of the American Heart Association (AHA) on July 1. AHA is the nation’s leading voluntary health organization focused on the nation’s number one killer, cardiovascular disease, and stroke, which together claim more than 800,000 lives each year. Dr. Tomaselli is professor and director of the division of cardiology at the Johns Hopkins University School of Medicine, where he has worked for the past 25 years.